In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation.
- DOI
- 10.1016/j.jgeb.2024.100429
- Published
- 2024 Dec
- Container
- Journal, genetic engineering & biotechnology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jgeb.2024.100429,
title = {In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation.},
author = {Anis A and Mostafa AM and Kerema MS and Hamdy NM and Sultan AS},
year = {2024},
journal = {Journal, genetic engineering \& biotechnology},
doi = {10.1016/j.jgeb.2024.100429},
url = {https://doi.org/10.1016/j.jgeb.2024.100429}
}RIS
TY - JOUR TI - In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation. AU - Anis A AU - Mostafa AM AU - Kerema MS AU - Hamdy NM AU - Sultan AS PY - 2024 JO - Journal, genetic engineering & biotechnology DO - 10.1016/j.jgeb.2024.100429 UR - https://doi.org/10.1016/j.jgeb.2024.100429 ER -
APA
A, A., AM, M., MS, K., NM, H., & AS, S. (2024). In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation.. Journal, genetic engineering & biotechnology. https://doi.org/10.1016/j.jgeb.2024.100429
Source records
- pubmed · retrieved 2026-09-27T01:30:15.228Z